“genzyme” Archives

Entry Author Date Location
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
In 2015, U-M Tech Transfer Topped Record-Breaking 2014 Numbers 09/22/15 Detroit Ann Arbor
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap 03/04/15 San Francisco
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Roundup: NextEnergy, Start Garden, LLamasoft, Atterocor, U-M, More 11/20/14 Detroit Ann Arbor
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval 09/11/14 Detroit Ann Arbor
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Page 1 of 16 next page »